Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TODAY: Titration of Avonex in RRMS
NCT00574041Phase 4Terminated
- Sponsor
- Biogen
- Start
- Jun 2007
- Primary completion
- Feb 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon beta-1a in relapsing-remitting multiple sclerosis (RRMS), sponsored by Biogen. Started Jun 2007; status: terminated.
02
Drugs
interferon beta-1a
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00574041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574041.